Literature DB >> 12514210

Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats.

Juan J Toledo-Aral1, Simón Méndez-Ferrer, Ricardo Pardal, Miriam Echevarría, José López-Barneo.   

Abstract

We studied the mechanisms underlying long-term functional recovery of hemiparkinsonian rats grafted intrastriatally with carotid body (CB) cell aggregates. Amelioration of their motor syndrome is a result of the trophic actions of these grafts on the remaining ipsilateral substantia nigra neurons rather than of the release of dopamine from the CB grafts. The grafts maintain a stable morphological appearance and differentiated cell phenotype for the duration of the life of the host. Adult CB expresses high levels of glial cell line-derived neurotrophic factor (GDNF) and the multicomponent GDNF receptor complex. These properties may contribute to the trophic actions of the CB transplants on nigrostriatal neurons and to their extraordinary longevity. We show that CB glomus cells, although highly dopaminergic, are protected from dopamine-mediated oxidative damage because of the absence of the high-affinity dopamine transporter. Thus, intrastriatal CB grafts are uniquely suited for long-term delivery of trophic factors capable of promoting restoration of the nigrostriatal pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12514210      PMCID: PMC6742142     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  18 in total

Review 1.  The neurogenic niche in the carotid body and its applicability to antiparkinsonian cell therapy.

Authors:  José López-Barneo; Ricardo Pardal; Patricia Ortega-Sáenz; Rocío Durán; Javier Villadiego; Juan José Toledo-Aral
Journal:  J Neural Transm (Vienna)       Date:  2009-03-05       Impact factor: 3.575

2.  Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.

Authors:  Rebeca Mejías; Javier Villadiego; C Oscar Pintado; Pablo J Vime; Lin Gao; Juan J Toledo-Aral; Miriam Echevarría; José López-Barneo
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

Review 3.  The carotid body: a physiologically relevant germinal niche in the adult peripheral nervous system.

Authors:  Verónica Sobrino; Valentina Annese; Elena Navarro-Guerrero; Aida Platero-Luengo; Ricardo Pardal
Journal:  Cell Mol Life Sci       Date:  2018-11-29       Impact factor: 9.261

Review 4.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

5.  Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.

Authors:  Timothy J Collier; Jennifer O'Malley; David J Rademacher; Jennifer A Stancati; Kellie A Sisson; Caryl E Sortwell; Katrina L Paumier; Kibrom G Gebremedhin; Kathy Steece-Collier
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

Review 6.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

7.  Cellular properties and chemosensory responses of the human carotid body.

Authors:  Patricia Ortega-Sáenz; Ricardo Pardal; Konstantin Levitsky; Javier Villadiego; Ana Belén Muñoz-Manchado; Rocío Durán; Victoria Bonilla-Henao; Ignacio Arias-Mayenco; Verónica Sobrino; Antonio Ordóñez; María Oliver; Juan José Toledo-Aral; José López-Barneo
Journal:  J Physiol       Date:  2013-10-28       Impact factor: 5.182

Review 8.  Advances in gene therapy for movement disorders.

Authors:  Hideki Mochizuki; Toru Yasuda; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 9.  Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies.

Authors:  Emilio Fernandez-Espejo
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

10.  GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.

Authors:  Sebastien Carnicella; Somayeh Ahmadiantehrani; Patricia H Janak; Dorit Ron
Journal:  Alcohol Clin Exp Res       Date:  2009-03-19       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.